Delivery Order SPE2DB25D3020-SPE2DB25FWKRY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,805.92 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packaging) with a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by November 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,457.00 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under a firm fixed-price contract. The award was made on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. Performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,122.38 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,638.00 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) under a firm fixed price contract type. The delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,259.49 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $11,793.60 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 17, 2025, and performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award...
- The Defense Logistics Agency awarded a delivery order valued at $15,763.14 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, with no set-aside designation applied. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. This contract represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,620.03 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages). This non-set-aside, firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,559.83 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,486.96 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. This non-set-aside award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKRYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,603.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under a firm fixed price contract. This non-set-aside award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the company's broader federal pharmaceutical supply portfolio and supports DLA's mission to provide essential medications to military and veteran healthcare systems. This award is a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated consistent capability to fulfill competitive federal requirements across multiple therapeutic domains, with delivery orders typically structured as firm fixed price transactions ranging from minimal values to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/18/25 |